Episode
Beyond the Drip: Kicking Off 2025 with Insights and Challenges
- Podcast
- Beyond the Drip Podcast
- Published
- Jan 30, 2025
- Duration seconds
- 2489
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/beyond-the-drip-podcast-6943564/episodes/beyond-the-drip-kicking-off-2025-with-insights-and-challenges/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/beyond-the-drip-podcast-6943564/beyond-the-drip-kicking-off-2025-with-insights-and-challenges.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Welcome to Beyond the Drip , where we dive into the fascinating world of Infusion Pharmacy, from Home Infusion to Ambulatory Infusion Centers. Expect topical conversations on the latest happenings in Infusion from industry leaders who will bring you the latest news, trends and innovations in the infusion industry, as well as expert insights and stories to keep you informed and inspired. As we step into 2025, the latest episode of Beyond the Drip sets the stage for a year filled with both opportunities and challenges in the infusion and pharmacy space. The hosts reflect on the key events of 2024 that shaped the industry, including major disruptions like the Change Healthcare cyberattack, supply chain issues and regulatory shifts. They also explore the pressing topics that will define 2025, such as drug pricing, revenue cycle management (RCM) hurdles and the expanding role of artificial intelligence (AI) in healthcare. Key Takeaways: Looking Back at 2024 The Change Healthcare cyberattack disrupted revenue cycles and patient care, with some providers still recovering. Supply chain disparities, highlighted by issues in North Carolina’s manufacturing plants, revealed inequities in home-based care access. Healthcare consolidation and private equity influence remain hot topics, with concerns about fair treatment in regulatory decisions. The industry showcased resilience despite these setbacks, adapting to rapid changes. What’s Ahead in 2025? Biologic products are growing rapidly, creating challenges in training staff and ensuring proper reimbursement. Providers struggle with securing payment for high-cost drugs due to unclear payor guidelines. The new administration’s approach to healthcare policy remains unpredictable. While AI has immense potential in RCM, patient safety ri…